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Abstract
Background: Non-adherence to drug therapy is common in Inflammatory Bowel Disease (IBD).
Patients' beliefs about treatment have an important influence on adherence. An in-depth
understanding of this area is, therefore, important for patient-centred care. The aim of the study
was to assess patients' perspectives and beliefs about their medication and to determine how this
relates to medicine taking and other related health behaviour as part of a larger qualitative study
on health care related behaviour in patients with IBD.
Methods: Individual semi-structured interviews and focus groups. An iterative approach following
principles of grounded theory was applied to data collection and analysis.
Results: Main emerging themes were: balance of perceived necessity versus concerns, perceived
impact of symptoms and willingness to self-manage medication. There was a clear distinction made
between steroids and other preparations. Concerns included the fear of both short and long-term
side-effects (mainly steroids), uncertainties about drug interactions and development of long-term
immunity. Adapting to and accepting medication use was linked to acceptance of IBD.
Conclusion: A concordant approach including flexible and pro-active support as well as accurate
information is important in assisting patients with IBD to self-manage their medication effectively.
Health professionals should be aware that attitudes to medicine taking and other related
behaviours may be medicine specific and change over time.
Background
Inflammatory Bowel Disease (IBD) is a chronic disorder
characterised by periods of remission and unpredictable
relapses. Although there is currently no cure, medical
management of the disease includes long-term drug ther-
apy which can be effective in inducing or maintaining
remission. Non-adherence to long-term medical therapy
is common in chronic disease and typically tends to be
around 30–40% [1,2]. Differences in measurement, defi-
nition and context, however, can influence reported
adherence rates, correlates and outcomes [3]. Reported
non-adherence rates in IBD range from 5% to 60% [3,5-
8]. Known influential factors on adherence in IBD include
socio-demographic characteristics, dosing, depression,
disease awareness, the therapeutic relationship, disease
activity and psychosocial characteristics [1,5-11]. Within
the wider literature on adherence, there is evidence to sug-
gest that patients' treatment and illness beliefs have an
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important influence on their decisions about treatment
[1,9,12-15] and that many people have fairly negative or
ambivalent views of medicines [16,17]. Little, however, is
known about the attitudes and beliefs that IBD patients
have regarding their medication despite evidence of con-
siderable concerns over medication side-effects within
this group of patients [18]. Furthermore, research suggests
that patients are reluctant to discuss concerns about med-
ication with their doctor [19]. An in-depth understanding
of patient treatment beliefs is therefore important for
patient-centred care in IBD. We undertook a qualitative
analysis of patients' beliefs about drug treatment and how
this affected their use of medications as part of a larger
study on IBD patients' beliefs and attitudes towards their
condition and health care seeking behaviour. The analysis
of the latter study centred around the core concept of
"health-related normality" and is reported elsewhere [20].
This paper presents a further in-depth analysis of the
issues surrounding "medicine taking" and related health
behaviours which were important elements within the
narratives of the respondents.
Methods
Design and participants
58 individuals with established IBD, defined as more than
two years since diagnosis, were invited to participate. All
those invited had scored in the lowest quartile of a disease
specific health-related quality of life measure, the UK-
IBDQ [21], in a previous study of a community popula-
tion from the North East of England [22]. It was antici-
pated that these individuals would have a wide range of
experience of relapse and medicine taking due to their low
health-related quality of life scores. 31 individuals partic-
ipated in the research (19 female and 12 male). 17 had a
diagnosis of ulcerative colitis and 14 crohn's disease. 15
took part in individual interviews (10 female and 5 male,
mean age 48.3 years, range 26 years to 68 years) and a fur-
ther 16 in three focus groups (1 female group (n = 7, mean
age 46.6 years, range 37 years to 61 years), 1 male group
(n = 6, mean age 49.6 years, range 36 years to 72 years)
and 1 mixed group (n = 3, mean age 77.4 years, range 76
years to 79 years)). Participants were predominantly from
an urban setting but showed diversity in terms of their
socio-demographic characteristics and included patients
not under specialist care.
Because detailed instructions of the methods employed
have been published elsewhere [20], only a brief sum-
mary is presented here. Individual interviews were con-
ducted at the respondent's home by either NH or AD.
Focus groups were facilitated by both NH and AD. The
interview agenda covered individuals' perspectives of their
experiences and understandings of their illness, health
care seeking behaviour and medication. A flexible
approach was employed which allowed emergent themes
to be incorporated into later interviews following princi-
ples of grounded theory [23]. All interviews and focus
groups were tape recorded and transcribed verbatim with
the participants' written consent. Interviews continued on
a theoretical sampling basis until saturation of themes
was reached. Approval was obtained from North Tees
Local Ethics Committee.
Analysis
Concurrent data collection and analysis was undertaken
based on principles of grounded theory. The computer
software QSR NUD.IST was used to aid indexing and
charting. Open and axial coding was carried out inde-
pendently by NH and AD. Where discrepancies existed
these were discussed with a third researcher until a con-
sensus was reached. Examples of open codes included:
benefits of medication, side-effects and supply of medica-
tion at home. Throughout the analysis, accounts, inform-
ants and categories were compared for differences and
similarities between them using a constant comparative
approach [24]. Data collection continued until no new
categories could be found i.e. saturation had been
achieved. Respondent validation was obtained by asking
respondents to indicate on a five point Likert scale
whether initial findings reflected a true representation of
their opinion or that of the group (97% either agreed or
strongly agreed). Participants were also given the opportu-
nity to add further comments and these were incorporated
into the ongoing analysis. The core category of "health-
related normality" has been described elsewhere [20].
This paper is based on a further in-depth description of
the emerging category "medication", which was found to
be an important element within the narratives of the
respondents during the analysis and was closely linked to
the core category. This analysis was completed following
the writing and re-writing process [25] and complements
the previously published paper. Particular attention was
paid to re-reading the original transcripts and the use of
the constant comparison method to ensure that the anal-
ysis remained grounded in the narratives of the respond-
ents.
Results
Participants offered rich in-depth narratives of their expe-
riences with medication, particularly in regards to side-
effects. In general, there was a clear knowledge about the
names, dosages and uses of their medications including
those for other medical conditions. Medication was an
important aspect of the participants' lives and they took
advantage of the focus groups to share their experiences
and reflect upon these in an open way. They showed inter-
est in the medication of other participants and used the
group to normalise their own experiences. Participants
had both positive and negative conflicting attitudes
towards their medication. The main emerging themes cen-BMC Gastroenterology 2007, 7:20 http://www.biomedcentral.com/1471-230X/7/20
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tred on their acceptance and perceived necessity of their
medication, the fears and concerns held towards their
medication, the perceived impact, actual or potential, that
their illness and symptoms had on their lives and willing-
ness to self-manage. The ways in which patients used and
self-managed their medicines were determined by an ever-
changing balance between their beliefs about their medi-
cation and the impact of the illness. The perceived need
for pain relief or corticosteroid treatment, for example,
can be an important crisis trigger for seeking health care
when the necessity of the medication outweighs the barri-
ers to seeking care or the concerns about side-effects, par-
ticularly when the perceived impact of the symptoms is
felt to be high. Figure 1 illustrates how the category of
medicine taking and other associated health behaviours
relates to the beliefs about the acceptance and perceived
necessity of medication, the balance of fears and concerns
and the perceived impact of symptoms. Experience of the
illness, knowledge and the relationship with the health
care provider can also be influential in this process. This is
followed by a more in-depth explanation of the elements
within the model.
Acceptance and perceived necessity of medication
For the majority of participants, medication was seen as
necessary in controlling symptoms or flare-ups despite
being seen as a nuisance, concerns for side-effects (mainly
steroids) and anti-drug feelings. Acceptance of the neces-
sity to take medication was something that was seen to
happen over time and was linked to acceptance of the ill-
ness (see table 1).
Despite general anti-drug feelings, taking medication for
IBD had became a normal part of everyday life in the same
way that living with the consequences of IBD symptoms
had. Moreover, it also allowed the maintenance of what
was considered to be a "normal life" in that controlling
the symptoms with medication meant decreasing the
impact of actual or potential distressing symptoms and
embarrassment associated with the illness. "It (taking med-
ication) is something that I do everyday now. So it is nothing
out of the ordinary really." (female with ulcerative colitis, 36
years). Nonetheless, for some participants, due to the
nature of the disease, being "ill" was sometimes seen as a
periodical rather than a continual state and referred to
times of flare-up. In these instances, medication taking
only occurred during times of "illness". "I only take it (med-
ication) when I need to take it. I wouldn't like to be perma-
nently on medication I suppose, only if I had a really good
reason to be.., I mean I will take it when I am ill..." (male with
ulcerative colitis, 38 years). Similarly, a participant in the
male focus group described his feelings regarding colif-
oam enemas, which he had been instructed to take regard-
less of whether he was feeling well. More importance was
placed on his negative feelings towards the treatment dur-
ing remission when the perceived necessity decreased. "In
the end I got sick of doing it because it's not natural to want
to,.. I am not being crude but sticking something like that up
your backside regardless if you are well or not." (male with
ulcerative colitis, 54 years).
Individual perceptions of the effects of medications were
important in determining perceived necessity. For
instance, a few participants described how they had "tested
the water" by coming off maintenance medication. Wors-
ening symptoms strengthened their beliefs about the
necessity of continued usage. Those participants unable to
identify such a direct link reported more inconsistency in
their medication taking (see table 2).
Although there was awareness of the need to monitor the
bowel for the development of cancer, for those patients
with ulcerative colitis on 5-ASA therapy, the prophylactic
effect of their maintenance medication against colorectal
cancer was not mentioned in either the focus groups or
Table 1: Acceptance of medication taking
"At the beginning it was very hard to come to terms with. You feel like you are pill-popping ... but now I have come to terms with the illness and it (taking tablets) 
is something that I live with. I just have to." (female with ulcerative colitis, 36 years)
"It's not a very nice feeling actually to know that you're going to be dependent on tablets for the rest of your life, especially when you're not keen on taking 
tablets.. I mean I know I have to and I will be taking them for the rest of my days, so you just have to accept it don't you?" (female with crohn's disease, 44 
years)
Model of relationship between categories Figure 1
Model of relationship between categories.
Fears/concerns Acceptance of 
medication 
Perceived impact of actual 
or potential symptoms 
Medicine taking and 
related health behaviours
Willingness to self-manage
Seeking health care 
Evidence of concordance
Relationship with 
health care provider 
Knowledge and 
experience BMC Gastroenterology 2007, 7:20 http://www.biomedcentral.com/1471-230X/7/20
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the interviews. Due to ethical considerations, being aware
of this particular benefit of the medication was not asked
as a direct question to groups or during interviews as the
researchers did not wish to instil concerns of cancer risk in
individuals who were not already aware.
Medication fears and concerns
There was a clear distinction made between steroids and
other preparations. Steroids were viewed a lot more nega-
tively than the other "regular" medication taken for IBD
and the fear of dependency was greater. Participants
talked about both long and short-term side-effects. "It's
(taking medication) a fact of life... It is something you have to
do to make life bearable; it doesn't bother me at all... They
(steroids) bother me... I wouldn't like to be on steroids long-
term." (female with ulcerative colitis, 65 years). "That's
what's given me the osteoporosis." (male with crohn's dis-
ease, 31 years). In general the short-term effects were non-
gender specific and verbalised as: "I got mood swings", "it
just wasn't me", "you feel euphoric", "I could have eaten the
bricks on the wall". Fear of being prescribed steroids could
in some cases result in a delay in seeking health care. Expe-
rience of the effects of the treatment could, nevertheless,
counteract some of the negative attitudes. One woman
with ulcerative colitis, for example, described her fear of
dependency on steroids after a serious flare-up when her
"normal" medication "had stopped working". She had been
surprised that her course of steroids had only lasted one
week before an improvement in symptoms was evident
and this experience had alleviated her fear of further
courses, despite her continuing concerns about side-
effects (see table 3).
Negative attitudes to drugs, therefore, seemed to be
related to general anti-drug feelings and to specific con-
cerns regarding steroids, although some severe reactions
to azathioprine were also described. 5-ASA therapies did
not seem to present any specific concerns in the same way
as other medications could: "Asacol is OK", "they've put me
on Asacol. They're like a normal tablet", "I take the Asacol 3
times a day. If it's bad, I increase it to 4 or 5 times a day, the
enemas I keep down because of the cortisone as much as I can
... the codeine phosphate I keep off if I can", " I have a feeling
the Asacol is like a calming gel or something like that". Inter-
estingly the fear of surgery or the need for more "serious"
drugs could act as a reinforcer for the need to take medi-
cation regularly and seek health care at the first sign of a
relapse. "I know how serious it is now you see. At first I didn't,
at first I thought it was just a little thing that was passing
through and now I know what the other results could be if I
delayed. It could be a bag (colostomy) or more drugs more seri-
ous drugs." (male with crohn's disease, 26 years).
A range of other drugs were taken by participants, includ-
ing analgesics, loperamide, prochlorperazine, betablock-
ers, tranquilisers and antibiotics. Medication
management became increasingly more complex when
medication for other conditions was necessary. There
were concerns that medicines may interact with each
other, that the body becomes immune after long-term use
and a reluctance to be prescribed further medication.
These concerns were not always expressed to the doctor
and could be influential in delaying seeking care (see table
4).
Perceived impact of actual or potential symptoms
Balancing the concerns of taking medication and the con-
cerns of what might happen without medication was part
and parcel of everyday life for those living with IBD.
Uncontrolled symptoms could mean pain, embarrass-
Table 3: Steroidal preparations
"I have been told that if I get any bad flare-ups the next course of treatment after this Asacol is steroids and I have seen what steroids can do to different 
people. I have a friend on this steroidal thing for his chest and he's got a big jowl and it's just one of these things I am tempted to put off." (male with 
ulcerative colitis, 55 years).
" I didn't know it was only going to be a week and luckily things did resolve but I thought at the start that this was the start of me being dependent on them and 
I was concerned about that...I was so relieved when the symptoms subsided you know after a week." (female with ulcerative colitis, 56 years).
" but the steroids I must say they really did the trick. Big time." (male with ulcerative colitis 36 years)
"I was quite amazed at how fast the steroids started to work." (female with crohn's disease, 44 years)
Table 2: Testing the water
"about 2 years ago I tried not taking it (5 ASA therapy) to see what would happen and it did make the condition worse, so I went straight back on it and I take 
it now." (male with ulcerative colitis, 40 years)
"I don't like taking the amount of tablets they were giving me and what I was finding was that even when I was taking the tablets for 6 months I would still have 
flare-up. I could knock off the tablets for 6 months and have nothing so there didn't seem to be any cause and effect... I would take them for a couple of weeks 
and then I would lapse again." (female with ulcerative colitis, 42 years)BMC Gastroenterology 2007, 7:20 http://www.biomedcentral.com/1471-230X/7/20
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ment, faecal incontinence, interference with everyday
activities and potential surgery. Just as the acceptance of
medication develops over time, concerns over the conse-
quences of living with their illness could also alter with
experience, in particular with the severity and frequency of
relapses and ongoing symptoms. For many participants,
the fear of the impact of actual or potential symptoms is
in fine balance with how necessary they perceive their
medication to be (see table 5).
Willingness to self-manage
Almost two thirds of participants reported they were keen
to self-manage their medication. Around a third had a
supply of steroids available to take in case of relapse. This
saved them "bothering the doctor", waiting unnecessarily
for an appointment or having to get to the surgery when
fear of faecal incontinence made travel difficult. "so every
time I'm really ill, I take them (supply of steroids at home) .. I
don't mind doing that. I mean it's better than keep running to
the doctors all the time isn't it? You know I think he'd like me
to go more. I'm alright managing it myself to be honest". (male
with ulcerative colitis, 40 years). As mentioned above,
medication management became increasingly complex
when medication for other conditions was involved. Par-
ticipants provided detailed accounts of the numbers of
tablets they took and when they had to be taken. Most of
them were keen to self-manage their medication and
many felt confident in increasing or decreasing their daily
dosage according to the course of their illness. The inabil-
ity to self-manage a flare-up or usual symptoms such as
pain or bleeding and thus the perceived need for steroids
or pain relief were the most important factors in seeking
health care. Responsibility for medication taking
belonged to the patient, albeit in certain cases after "per-
mission" from the doctor (see table 6).
Although some participants reported satisfactory relation-
ships with their doctor based on a negotiated approach,
directly challenging a doctors decision was felt to be inap-
propriate. "my doctor is fully supportive of me.. so he tends to
say okay what do you want to do with this and I say give me my
steroid enemas." (female with ulcerative colitis, 42 years).
"I feel azathioprine is the drug that gets me right and he (doc-
tor) always prescribes me steroids... you can't say anything, you
feel like you should. My consultant gets me right as soon as I
am on the azathioprine." (male with crohn's disease, 30
years). Although the doctor was often seen solely as a
"medication provider", the importance of good commu-
nication and information is evidenced by the following
quote from one female participant from the focus group.
"maybe there was some misinterpretation of what I was sup-
posed to do, but I didn't really feel I had enough knowledge to
actually handle my own problems.. I would take the tablets and
as soon as the symptoms stopped I just stopped taking the tab-
lets... I wasn't really sure what I was supposed to do and it's
been pointed out to me quite recently that I wasn't really using
the medication in the way that it was supposed to be used."
(female with ulcerative colitis, 36 years).
Discussion
When illness specific medications are felt necessary to
control symptoms that are significantly impacting on
quality of life, more general anti-drug beliefs can be com-
promised. How individuals deal with this conflict will
Table 5: Impact of actual or potential symptoms on attitudes to medication
"... you can't go anywhere without your tablets, you can't go anywhere without your Imodium you know. You walk around with a spare pair of knickers in your 
bag and wet wipes and everything just in case. ...I've only ever had one accident (faecal incontinence) and you know it frightened the life out of me." (female 
with crohn's disease, 44 years).
"so, I think if I didn't take them, I am sure I would be poorly." (female with ulcerative colitis, 56 years)
" do I keep throwing this amount of drugs into myself which I am sure must be helping me in some point but damaging me in another, or do I risk the ulcerative 
colitis giving me another year like I had last year, which was absolutely awful, so it's really again you are between a rock and a hard place." (female with 
ulcerative colitis, 42 years)
Table 4: Concerns over long-term and multiple medication use
"I keep looking at myself and thinking I am on blood pressure tablets, cholesterol tablets, beta-blockers, pain killers for your heart. I take something like nineteen 
tablets a day and think to myself Jesus, if I go to the doctors to see him about anything else I'll have even more tablets. I don't want more tablets, I want less 
tablets. And I keep thinking to myself I'll go to the doctors and say "look are you sure these tablets are doing me any good? Isn't one counteracting one which is 
counteracting another, can't you cut them down?" (male with ulcerative colitis, 55 years)
"I've reached saturation level as far as drug therapies are concerned and the consequence of that is that I'm developing other problems." (male with ulcerative 
colitis, 65 years)
"They fight with each other these tablets as they are going down.. I take 2 sleeping tablets; I take my paracetamol, my codeine, my folic acid and my 
prednisolone. It's a wonder you don't OD really, all these tablets." (female with crohn's disease, 58 years)BMC Gastroenterology 2007, 7:20 http://www.biomedcentral.com/1471-230X/7/20
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affect their medicine taking in different ways and may
change over time. It is possible, moreover, that patients
develop more positive attitudes towards specific medica-
tions in order to reduce the conflict between the require-
ment to take a medication everyday and their negative
feelings towards taking drugs. For example, those patients
who have negative views of drug taking may, nevertheless,
perceive the benefits of their 5-ASA therapy to outweigh
any harm due to the necessity of controlling symptoms.
To reduce this inconsistency, it is possible that they re-
assign more positive specific beliefs to their 5-ASA ther-
apy, such as perceiving it to be a "calming gel" or "normal
medicine". This is potentially easier to achieve in the
absence of side-effects or through direct experience of its
benefits. Although, the fairly positive attitudes to mainte-
nance 5-ASA therapy in contrast to steroids can be
explained in terms of a lack of experienced side-effects or
by differing routes of administration, negative attitudes to
steroids were, nevertheless, less important when their
necessity was deemed greater or when they were out-
weighed by their positive effects on the maintenance of
usual activities.
The health care provider is often seen as the "medication
provider", whereas many patients see their role as "medi-
cation manager", particularly in regards to altering dos-
ages and taking steroids during flare-ups. "Permission"
from their doctor to self-manage can help promote posi-
tive feelings of control and trust within this role. Sufficient
information, however, is required to enable patients to
self-manage their medication safely and effectively. Beliefs
about medication can inhibit seeking health care when
the concerns are high but also promote seeking care when
the necessity is high.
Relation to other studies
The importance of health beliefs in adherence to a treat-
ment regime is well recognised [1,2]. Our findings are
compatible with existing theories and models of health
behaviour. For example, the balance of concerns and
acceptance of the necessity of medication is similar to the
concepts of perceived barriers and benefits of action from
the health belief model [26] as well Horne and Wein-
man's research [13] on perceived risks and benefits in
medication adherence. The narratives of participants in
our research mirrored those reported by Townsend et al
[16] on individuals with chronic multiple morbidities in
that they "self regulated their drug use in an attempt to
gain equilibrium, relief from symptoms or sense of a nor-
mal life", and showed a "reluctance to take drugs yet an
inability to be free of them". Sewitch et al [7] suggest that
health beliefs play a stronger role than quality of life or
patient/physician relationship in the variance in medica-
tion taking intention, but that those with more severe dis-
ease were more likely to consider the costs and the
benefits rather than just the costs as is the case with those
with less severe disease. Their findings suggest that
patients with more experience of IBD may be less likely to
deliberately stop taking their medication. It is possible
that the participants in our study, who had all been diag-
nosed for at least two years and had all experienced very
low disease related quality of life, may weigh up the ben-
efits and costs of their medication differently to those with
a more recent diagnosis, or whose disease related quality
of life has not been affected to the same extent. This may
be worthy of further research as acceptance of medication
and the illness were related and occurred over time. The
link between acceptance of illness and medication use has
also been described in qualitative research in other
chronic diseases which has identified different types of
medicine user [15,27]. Narratives from this study suggest
that the way individuals use their medication changes
over time and with experience of their illness. A quarter of
patients with IBD are already treating relapses themselves
without guidance and guided self-management can
reduce health provision costs and increase confidence in
patients' ability to cope with their condition [28-30]. We
found that many patients have positive attitudes towards
managing their own medication and are often already
self-managing. This study, moreover, also highlights the
importance of medication for respondents in maintaining
a "normal life" and details how a patient's relationship
with their health care provider can influence the way in
which they manage their medication and, ultimately,
their illness. Some evidence, nonetheless, suggests that
adherence in GI diseases has shown an upward trend over
the last 50 years and is higher than in many other com-
mon conditions [4]. It is possible that improvements in
treatment options and care provision for IBD have
resulted in increased confidence and more positive expe-
riences of maintenance therapy.
Strengths and weaknesses
As a qualitative study, the usefulness of our findings lies
in the rich narratives which allow an in-depth description
of the beliefs and attitudes towards medication among
Table 6: Self-management
"So usually what they tend to do is give me 100 tablets. It is nice in the sense that they trust me that I know how to control it." (female with ulcerative colitis, 
30 years).
"I would just increase it (medication) myself now... before I used to go (to the doctor) really just to get the go ahead to increase. Well now I don't feel that I have 
to, so there's a bit more knowledge that's just come with experience." (female with ulcerative colitis, 56 years).BMC Gastroenterology 2007, 7:20 http://www.biomedcentral.com/1471-230X/7/20
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patients with IBD. Triangulation of methods and analysis
strengthen the validity of the study. Participants were
diverse in their demographic characteristics and extent of
their disease and included patients not under specialist
care. Because of the low prevalence of minority ethnic
groups in the study area, only one perspective from a
patient of Asian origin was gained and further research
would be necessary for comparisons of patients from dif-
ferent cultural backgrounds. Participants were selected
from those with the lowest quality of life scores from a
previous community based survey of individuals with
established IBD [22] to allow for narratives that drew
upon a variety of experiences in terms of relapse fre-
quency, disease severity and medicine taking. Rubin et al's
findings indicate that these patients are most likely to be
under specialist care for IBD and therefore provide a range
of views from patients usually accessible to health care
providers [22]. Further research would, however, be nec-
essary to identify differences in medication beliefs in
patients with better quality of life, with more recent onset
of disease, under different care conditions and with differ-
ent levels of actual adherence.
Implications for practice
This study provides an in-depth understanding of the con-
cerns and beliefs that patients with IBD have about medi-
cation and how these can change over time. Pro-actively
eliciting patients' beliefs about specific medications and
their attitudes towards their illness can provide useful
indicators of potential adherence to their medication
regime. In addition, the findings suggest that many IBD
patients are keen to self-manage their medication and
may already be doing so to varying degrees. Accurate
information on potential risks and benefits of medica-
tions as well as support, encouragement and feedback are
needed to enable patients to do this safely. Managing this
process effectively may not only have a positive effect on
adherence but could potentially improve the doctor/
patient relationship, satisfaction with care, health out-
comes and health related quality of life, and result in
more efficient use of health care services. Supporting
patients effectively to self-manage their condition is not a
straightforward task, however, and training in this area
may be beneficial [30-34].
Conclusion
We conclude that, in patients with IBD, perceived neces-
sity of medication is weighed against general and specific
concerns as well as outcome expectancies. This process is
related to acceptance of their diagnosis and their illness
and can therefore change over time, with experience and
in some cases with disease activity. The findings are com-
patible with existing models of health behaviour and
research from other chronic diseases. More in-depth
understanding of the concerns and beliefs that patients
with a relapsing chronic illness such as IBD have about
medication and how these change over time could sup-
port better guided self-management, and may improve
health status.
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